loading page

Uterine transplantation: Legal and regulatory implications in the UK
  • +5
  • Saaliha Vali,
  • Benjamin Jones,
  • Srdjan Saso,
  • Michael Fertleman,
  • Amel Alghrani,
  • Giuliano Testa,
  • Liza Johannesson,
  • J Richard Smith
Saaliha Vali
Imperial College Healthcare NHS Trust
Author Profile
Benjamin Jones
Imperial College London
Author Profile
Srdjan Saso
Imperial College London
Author Profile
Michael Fertleman
Imperial College Healthcare NHS Trust
Author Profile
Amel Alghrani
University of Liverpool
Author Profile
Giuliano Testa
Baylor University Medical Center at Dallas
Author Profile
Liza Johannesson
Baylor University Medical Center at Dallas
Author Profile
J Richard Smith
Hammersmith Hospital
Author Profile

Abstract

Uterus transplantation (UTx) is fast evolving from an experimental to a clinical procedure, combining solid organ transplantation with assisted reproductive technology. The commencement of the first human uterus transplant trial in the UK leads us to examine and reflect upon the legal and regulatory aspects closely intertwined with UTx from the process of donation to potential implications on fertility treatment and the birth of the resultant child. As the world’s first ephemeral transplant, the possibility of organ restitution requires consideration and is discussed herein. Public funding of fertility treatments pertaining to UTx remains variable and warrants review.

Peer review status:ACCEPTED

03 Mar 2021Submitted to BJOG: An International Journal of Obstetrics and Gynaecology
04 Mar 2021Submission Checks Completed
04 Mar 2021Assigned to Editor
09 Mar 2021Reviewer(s) Assigned
28 Mar 2021Review(s) Completed, Editorial Evaluation Pending
03 Apr 2021Editorial Decision: Revise Major
20 Apr 20211st Revision Received
23 Apr 2021Submission Checks Completed
23 Apr 2021Assigned to Editor
23 Apr 2021Review(s) Completed, Editorial Evaluation Pending
27 Apr 2021Editorial Decision: Accept